Federal prosecutors in the US claim Ranbaxy has misled the US government about the quality of its generic medicines and are seeking access to documents from the Indian company. Ranbaxy says the allegations are baseless.
Business Week
Economic Times
Tuesday 15 July 2008
Ranbaxy faces US probe over quality
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment